All articles by GlobalData Healthcare

Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM

The cystic fibrosis (CF) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and…
Insmed scores pivotal win in bronchiectasis with FDA approval of Brinsupri

The US Food and Drug Administration (FDA) approval of Insmed’s Brinsupri marks a significant advancement in the treatment landscape of…
ESC 2025: Higher leg muscle scores reduce cardiovascular risk independent of BMI

This Monday (1 September) at the European Society of Cardiology (ESC) meeting in Madrid, the link between dietary intake, leg…
Four drugs race for first bispecific ADC approval

Bispecific (bs) antibody drug conjugates (ADCs) are an emerging therapeutic approach that present advantages over traditional ADCs. With 84% of…
2024 saw growth recovery for almost all top biopharma companies

The biopharmaceutical industry had a positive year in 2024, with obesity drug developers continuing to witness success. 19 of the…

AI is improving idiopathic pulmonary fibrosis care

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the lungs, leading…
Infectious disease screening during substance use disorder treatment increases detection, prevention, and treatment

According to the US Centers for Disease Control and Prevention, substance use disorder (SUD) affects approximately one in six people…
US eosinophilic oesophagitis market to reach $1.19bn by 2030

The eosinophilic oesophagitis (EoE) market in the US is forecast to grow from $202 million in 2020 to $1.19 billion…
South Korea emerges as 2025 licensing hub with 113% growth and billion-dollar deals

South Korea’s biopharmaceutical sector has seen a surge in innovator drug licensing agreements, reaching a total deal value of $7.86bn…
HS market forecast to reach $7.8bn across 7MM by 2034

The hidradenitis suppurativa (HS) market across the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)…